4572.T
Carna Biosciences,Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 409.00
+0.74%Margins
Gross margin
67.0%
EBITDA margin
—
EBIT margin
-358.2%
Net margin
-375.0%
FCF margin
-374.5%
-702.6%
Return on equity
-176.6%
Return on assets
-653.4%
Return on invested capital
0.42x
Asset turnover
-JPY 2.2B
Cash from operations
JPY 27
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026